ATP has invested over $2 billion in breakthrough innovations.


 

Aphios Corporation-

Cell Tissue Systems-

Chesapeake PERL, Inc.-

eSpin Technologies-

Gemini Life Sciences, Inc.-

Gryphon Therapeutics-

ISCA Technologies, Inc. -

ISTO Technologies-

Phoenix Science & Technology, Inc.-

RheoGene, Inc.-

RheoGene, Inc.-

Starthis, Inc.-

StrataGent Life Sciences Inc.-

Vaccinex, Inc.-

Back to Top

 
 
© Copyright 2005 PreFlight Ventures, Inc. All rights reserved.     Privacy Policy | Terms of Use
Site design and maintenance by Atlantic BT.